FDA inspection
Apotex Research Private Limited: FDA inspection ending Mar 15, 2024
FDA inspection 1233067 · Voluntary Action Indicated (VAI) · Bengaluru
Key facts
| Inspection ID | 1233067 |
|---|---|
| Firm | Apotex Research Private Limited |
| FEI number | 3006076314 |
| Address | Plot No.1 And 2, Bommasandra Industrial Area, 4th Phase, Jigani Link Rd |
| City | Bengaluru |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Mar 15, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data